Cingulate (CING) Earnings Date, Estimates & Call Transcripts $4.19 +0.20 (+5.01%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$4.03 -0.16 (-3.82%) As of 08/22/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cingulate Earnings Summary Cingulate announced Q2 2025 earnings on August 19, 2025, reporting an EPS of -$1.09, which missed analysts' consensus estimates of -$0.82 by $0.27. With a trailing EPS of -$4.10, Cingulate's earnings are expected to grow next year, from ($11.69) to ($4.95) per share. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 19) -$0.82 Actual EPS (Aug. 19) -$1.09 Missed By -$0.27 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)CING Upcoming EarningsCingulate's next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Powered by Get Cingulate Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cingulate and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCING Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Cingulate Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.05-$0.96-$1.01Q2 20252-$0.93-$0.87-$0.90Q3 20251-$0.58-$0.58-$0.58Q4 20251-$0.56-$0.56-$0.56 Cingulate Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/19/2025Q2 2025-$0.82-$1.09 -$0.27-$1.09--5/8/2025Q1 2025-$1.00-$1.04 -$0.04-$1.04--11/7/2024--$2.22-$1.83+$0.39-$1.83--8/13/2024--$5.64-$5.47+$0.17-$5.47--5/8/2024Q1 2024 -$2.20-$0.60+$1.60-$0.60--11/13/2023Q3 2023 -$4.80-$6.00 -$1.20-$6.00-- Cingulate Earnings - Frequently Asked Questions When is Cingulate's earnings date? Cingulate has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on CING's earnings history. Did Cingulate beat their earnings estimates last quarter? In the previous quarter, Cingulate (NASDAQ:CING) missed the analysts' consensus estimate of ($0.82) by $0.27 with a reported earnings per share (EPS) of ($1.09). Learn more on analysts' earnings estimate vs. CING's actual earnings. How much profit does Cingulate generate each year? Cingulate (NASDAQ:CING) has a recorded net income of -$15.55 million. CING has generated -$4.10 earnings per share over the last four quarters. What is Cingulate's EPS forecast for next year? Cingulate's earnings are expected to grow from ($11.69) per share to ($4.95) per share in the next year. More Earnings Resources from MarketBeat Related Companies Alto Neuroscience Earnings Results Oramed Pharmaceuticals Earnings Results Invivyd Earnings Results Vaxart Earnings Results Celularity Earnings Results Elutia Earnings Results BeyondSpring Earnings Results eXoZymes Earnings Results PMV Pharmaceuticals Earnings Results Oncobiologics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:CING) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access